Apixaban Clinical Trials in Maplewood, MN
As of July 2026, 1 paid clinical trial is testing Apixaban in Maplewood, Minnesota. Trials typically compensate participants for time, travel, and study visits, and many also provide study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial testing Apixaban
Top Research Study Locations in Maplewood
Researchers run research studies in Maplewood, MN at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint John's Hospital - Healtheast | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | 55 |
| Minnesota Oncology Hematology PA-Maplewood | Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8 | 49 |
| M Health Fairview St. John's Hospital | Atrial Fibrillation, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 6 |
| Minnesota Oncology Hematology, P.A. | Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 4 |
| Fairview Health Services | Acute Myocardial Infarction (AMI), Atrial Fibrillation (AF), Cardiovascular Risk | 2 |
| Fairview Health Services M Health Fairview St Johns Hospital | Obesity, Atherosclerotic Cardiovascular Disease, Heart Failure With Mildly Reduced Ejection Fraction | 2 |
| Minnesota Oncology Hematology, PA | Colorectal Neoplasms, Triple Negative Breast Cancer | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| Fairview Health | Heart Failure | 1 |
| Headlands Research-Twin Cities | Obesity, Overweight, Sleep Apnea, Obstructive | 1 |
| Health East Cancer Care | Cardiovascular Disease | 1 |
| M Health Fairview St. John's | Acute Infection, Organ Failure, Sepsis | 1 |
| Minnesota Oncology Hematology PA | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| Site 0288 - Minnesota Oncology Hematology - Maplewood | High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer | 1 |
| St. John's | Acute Infection, Organ Failure, Sepsis | 1 |
| Twin Cities Surg Ctr Maplewood | Lumbar Spinal Stenosis | 1 |
| USOR - Minnesota Oncology-Maplewood Clinic | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
| USOR - Minnesota Oncology/ Maplewood Clinic | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
| USOR Minnesota Oncology Hematology | Breast Adenocarcinoma, Endometrial Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC) | 1 |
Active & Upcoming Studies in Maplewood (2026)
Recruiting trials in Maplewood grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (65 active studies)
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (4 active studies)
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight · Phase 3 · Eli Lilly and Company
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
Cardiovascular (4 active studies)
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation · Phase 2 · Regeneron Pharmaceuticals
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity · Phase 3 · Amgen
Neurology & pain (2 active studies)
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight · Phase 3 · Eli Lilly and Company
- The CONFORM Pivotal Trial · Conformal Medical, Inc
Mental health & behavior (1 active study)
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Common conditions studied in Maplewood
- Malignant Solid Neoplasm (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (3 active studies)
- Clinical Stage III Esophageal Adenocarcinoma AJCC v8 (3 active studies)
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 (3 active studies)
- Malignant Female Reproductive System Neoplasm (3 active studies)
Leading research sponsors in Maplewood
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Maplewood?
There are approximately 88 recruiting clinical trials in Maplewood, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Maplewood pay participants?
Most recruiting trials in Maplewood compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Maplewood?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Maplewood?
The most common conditions under active study in Maplewood include Malignant Solid Neoplasm (4), Anatomic Stage II Breast Cancer AJCC v8 (3), Anatomic Stage IV Breast Cancer AJCC v8 (3), Clinical Stage III Esophageal Adenocarcinoma AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Maplewood?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Maplewood on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Maplewood?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Maplewood?
Recruiting research sites in Maplewood include Saint John's Hospital - Healtheast, Minnesota Oncology Hematology PA-Maplewood, M Health Fairview St. John's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Maplewood right now?
The largest active categories in Maplewood are Cancer & tumors (65), Diabetes & metabolic (4), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.